# GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Canadian Cancer Trials Group · Condition: Alveolar Soft Part Sarcoma

- Company: Canadian Cancer Trials Group
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07297667

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.